Generation of pluripotent cancer-initiating cells from transformed bone marrow-derived cells

Cancer Lett. 2011 Apr 28;303(2):140-9. doi: 10.1016/j.canlet.2011.01.021. Epub 2011 Feb 19.

Abstract

Our previous studies indicated that pluripotent cancer-initiating cells existed in chemical carcinogen-transformed mouse bone marrow-derived cells (BMDCs). In this report, we named them as bone marrow-derived pluripotent cancer-initiating (bmPCI) cells. The bmPCI cells showed properties of embryonal carcinoma (EC) cells/embryonic stem (ES) cells in morphology and gene expression, differentiated into multiple somatic tumor cells, generated oocyte-like cells and later developed into blastocyst-like structures in vitro while causing teratocarcinomas in vivo. These findings demonstrate that pluripotent cancer-initiating cells can originate from BMDCs. It provides an accessible in vitro model for copying the "embryonal rest" phenomenon from adult cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Blastocyst / metabolism
  • Bone Marrow Cells / cytology*
  • Carcinoma, Embryonal / metabolism*
  • Cell Culture Techniques*
  • Cell Differentiation
  • Embryonic Stem Cells / cytology*
  • Female
  • Male
  • Mice
  • Oocytes / cytology
  • Oocytes / metabolism
  • Pluripotent Stem Cells / cytology*
  • Pluripotent Stem Cells / metabolism*
  • Reverse Transcriptase Polymerase Chain Reaction
  • Stem Cells / cytology
  • Teratocarcinoma / metabolism